Free Trial

Victrex (LON:VCT) Shares Down 8.4% - Here's Why

Victrex logo with Basic Materials background

Victrex plc (LON:VCT - Get Free Report) shares fell 8.4% on Tuesday . The stock traded as low as GBX 667.62 ($9.08) and last traded at GBX 720 ($9.79). 827,259 shares changed hands during trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.69).

Victrex Stock Performance

The company has a current ratio of 4.39, a quick ratio of 1.99 and a debt-to-equity ratio of 10.93. The company has a market capitalization of £628.07 million, a price-to-earnings ratio of 20.46, a price-to-earnings-growth ratio of 1.92 and a beta of 0.69. The stock's fifty day simple moving average is GBX 800.54 and its 200-day simple moving average is GBX 894.36.

Victrex (LON:VCT - Get Free Report) last released its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share (EPS) for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. Analysts predict that Victrex plc will post 73.1078905 EPS for the current year.

Insider Buying and Selling

In other news, insider Dame Vivienne Cox acquired 2,747 shares of the firm's stock in a transaction dated Tuesday, July 8th. The stock was acquired at an average cost of GBX 721 ($9.80) per share, with a total value of £19,805.87 ($26,924.78). Also, insider David Thomas bought 1,158 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average price of GBX 846 ($11.50) per share, with a total value of £9,796.68 ($13,317.94). Corporate insiders own 1.64% of the company's stock.

About Victrex

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Victrex Right Now?

Before you consider Victrex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.

While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines